POINT Biopharma Global Future Growth
Future criteria checks 3/6
POINT Biopharma Global is forecast to grow earnings and revenue by 9.2% and 22.6% per annum respectively while EPS is expected to grow by 10.5% per annum.
Key information
9.2%
Earnings growth rate
10.5%
EPS growth rate
| Biotechs earnings growth | 21.1% |
| Revenue growth rate | 22.6% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 27 Dec 2023 |
Recent future growth updates
Recent updates
POINT Biopharma Global Inc. (NASDAQ:PNT) Analysts Just Slashed This Year's Estimates
Aug 20
We Think POINT Biopharma Global (NASDAQ:PNT) Can Easily Afford To Drive Business Growth
Feb 01A Look At The Fair Value Of POINT Biopharma Global Inc. (NASDAQ:PNT)
Oct 18Point Biopharma plummets on announcing common stock offering
Sep 13POINT Biopharma Global GAAP EPS of -$0.27 misses by $0.05
Aug 12Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 159 | -43 | 208 | 110 | 4 |
| 12/31/2024 | 69 | -41 | -35 | -135 | 7 |
| 12/31/2023 | 18 | -95 | -70 | -102 | 8 |
| 9/30/2023 | 244 | 97 | 93 | 112 | N/A |
| 6/30/2023 | 241 | 97 | 97 | 118 | N/A |
| 3/31/2023 | 236 | 98 | 156 | 172 | N/A |
| 12/31/2022 | 227 | 98 | 171 | 184 | N/A |
| 9/30/2022 | N/A | -79 | -78 | -65 | N/A |
| 6/30/2022 | N/A | -72 | -65 | -56 | N/A |
| 3/31/2022 | N/A | -56 | -54 | -44 | N/A |
| 12/31/2021 | N/A | -46 | -54 | -45 | N/A |
| 9/30/2021 | N/A | -37 | -48 | -38 | N/A |
| 6/30/2021 | N/A | -23 | -37 | -24 | N/A |
| 3/31/2021 | N/A | -18 | -29 | -19 | N/A |
| 12/31/2020 | N/A | -13 | -18 | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PNT's forecast earnings growth (9.2% per year) is above the savings rate (2.2%).
Earnings vs Market: PNT's earnings (9.2% per year) are forecast to grow slower than the US market (15.1% per year).
High Growth Earnings: PNT's earnings are forecast to grow, but not significantly.
Revenue vs Market: PNT's revenue (22.6% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: PNT's revenue (22.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if PNT's Return on Equity is forecast to be high in 3 years time